Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma

[1]  M. Gilbertson,et al.  Is CD20 positive plasma cell myeloma a unique clinicopathological entity? A study of 40 cases and review of the literature , 2012, Pathology.

[2]  J. Glassford,et al.  CD20‐positive multiple myeloma – differential expression of cyclins D1 and D2 suggests a heterogeneous disease , 2010, British journal of haematology.

[3]  N. Ngo,et al.  The significance of tumour cell immunophenotype in myeloma and its impact on clinical outcome , 2009, Journal of Clinical Pathology.

[4]  S. Rajkumar,et al.  Anti‐CD20 monoclonal antibody therapy in multiple myeloma , 2008, British journal of haematology.

[5]  Marina Ruggeri,et al.  Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders , 2008, Haematologica.

[6]  J. Hernández,et al.  Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma , 2005, Clinical Cancer Research.

[7]  R. Bataille,et al.  CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. , 2003, Blood.

[8]  A. Órfão,et al.  Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. , 2001, Cytometry.

[9]  R. Fonseca,et al.  The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. , 2000, American journal of clinical pathology.

[10]  A. Órfão,et al.  Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. , 1999, Blood.

[11]  Joan,et al.  Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. , 1998, The American journal of pathology.

[12]  J. Miguel,et al.  Cell surface markers in multiple myeloma. , 1994, Mayo Clinic proceedings.

[13]  A. Órfão,et al.  Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease , 1991, British journal of haematology.

[14]  R. Bartl,et al.  Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. , 1987, American journal of clinical pathology.

[15]  R. Fonseca,et al.  The ( 11 ; 14 ) ( q 13 ; q 32 ) Translocation in Multiple Myeloma A Morphologic and Immunohistochemical Study , 2002 .